vTv Therapeutics clinical trials we track

Check company identity source

Phase 3 1 trial

TrialDrugs studiedStatusPrimary completion
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 DiabetesNCT06334133Cadisegliatin 800 mg BID, Cadisegliatin 800 mg QDActive not recruiting2027-04Estimated

Phase 2 1 trial

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters